ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,117Medicare Part D Prescriptions Filled, Including Refills

Rank: 133 out of 1942

$468K Total Retail Price of All Prescriptions

Rank: 131 out of 1942

368 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 368 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 368 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,899 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 527 472 1 2
SIMVASTATIN 376 320 2 1
FUROSEMIDE 371 324 3 5
OMEPRAZOLE 345 281 4 4
AMLODIPINE BESYLATE 323 322 5 6
METOPROLOL SUCCINATE 293 249 6 13
ATORVASTATIN CALCIUM 237 233 7 14
LEVOTHYROXINE SODIUM 235 219 8 3
METOPROLOL TARTRATE 221 193 9 9
CITALOPRAM HBR 216 198 10 15
PRAVASTATIN SODIUM 189 169 11 23
GABAPENTIN 170 134 12 16
METFORMIN HCL 154 110 13 10
ATENOLOL 154 152 13 7
NAMENDA 148 137 15 51
ALENDRONATE SODIUM 138 122 16 21
HYDROCHLOROTHIAZIDE 127 117 17 8
ALLOPURINOL 114 109 18 26
PREDNISONE 111 87 19 27
ISOSORBIDE MONONITRATE ER 108 94 20 42
METFORMIN HCL ER 103 89 21 46
POTASSIUM CHLORIDE 100 80 22 17
AZITHROMYCIN 96 79 23 43
LOSARTAN POTASSIUM 94 80 24 18
SERTRALINE HCL 93 86 25 20
COMBIVENT 85 71 26 162
LOVASTATIN 78 75 27 32
TAMSULOSIN HCL 76 64 28 29
PROAIR HFA 75 64 29 41
ADVAIR DISKUS 73 70 30 35
PAROXETINE HCL 71 53 31 50
DIOVAN 70 70 32 44
RANITIDINE HCL 69 58 33 31
HYDROCODONE-ACETAMINOPHEN 63 45 S3 34 12
DIGOXIN 63 63 34 40
GLYBURIDE 58 54 R 36 69
TRAMADOL HCL 58 53 36 19
FENTANYL 57 49 S2 38 47
PANTOPRAZOLE SODIUM 57 52 38 48
ZOLPIDEM TARTRATE 54 47 40 25
TRAZODONE HCL 54 41 40 24
SPIRONOLACTONE 53 53 42 59
KLOR-CON M20 50 43 43 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.